Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Varicon Plus is a multi-ingredient formulation, typically marketed as a dietary supplement or topical treatment, designed to support vascular health and manage symptoms of chronic venous insufficiency (CVI). The product generally contains a combination of venotonic bioflavonoids, such as diosmin and hesperidin, alongside standardized herbal extracts like horse chestnut (*Aesculus hippocastanum*) and butcher's broom (*Ruscus aculeatus*). Its primary mechanism of action involves increasing venous tone by prolonging the activity of norepinephrine on the venous wall and reducing capillary permeability through the inhibition of enzymes like hyaluronidase and elastase. Additionally, it promotes lymphatic drainage and reduces inflammation in the microcirculation. Varicon Plus is commonly used to alleviate leg heaviness, pain, and swelling associated with varicose veins and prolonged standing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Varicon Plus.